<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24626660</article-id>
      <article-id pub-id-type="pmc">3938366</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20142803</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acquired epidermodysplasia verruciformis in a renal transplant recipient
- Case report<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mendes</surname>
            <given-names>Alena Darwich</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bittencourt</surname>
            <given-names>Maraya de Jesus Semblano</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moure</surname>
            <given-names>Emanuella Rosyane Duarte</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D'Mac&#xEA;do</surname>
            <given-names>Camila Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yamaki</surname>
            <given-names>Igor Nagai</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Ara&#xFA;jo</surname>
            <given-names>Dyandra Moreira</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD, Master's degree in Dermatology from Universidade do Estado do Rio
de Janeiro (UERJ) - Assistant Professor of Dermatology at Universidade do Estado do Par&#xE1;
(UEPA) and Head of the Dermatology Service at Centro Universit&#xE1;rio do Estado do Par&#xE1;
(CESUPA) - Bel&#xE9;m (PA), Brazil. </aff>
      <aff id="aff02"><label>2</label> MD, Master's degree in Tropical Diseases - Assistant professor of
Dermatology at Universidade Federal do Par&#xE1; (UFPA) and Internship professor of
Dermatology at Centro Universit&#xE1;rio do Estado do Par&#xE1; (CESUPA) - Bel&#xE9;m (PA), Brazil. </aff>
      <aff id="aff03"><label>3</label> MD, Master's degree in hair and nails from Universidade de S&#xE3;o Paulo
(USP) - Professor of Dermatology at Centro Universit&#xE1;rio do Estado do Par&#xE1; (CESUPA) -
Bel&#xE9;m (PA). Brazil </aff>
      <aff id="aff04"><label>4</label> Undergraduate medical student at Centro Universit&#xE1;rio do Estado do Par&#xE1;
(CESUPA) - Bel&#xE9;m (PA). Brazil </aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Maraya de Jesus Semblano Bittencourt, Avenida
Almirante Barroso, 3775, 66.613-903 - Bel&#xE9;m - PA, Brazil. E-mail:
<email>marayabittencourt@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>1</issue>
      <fpage>144</fpage>
      <lpage>146</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>5</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>7</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xAE;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 24-year-old male patient, who underwent kidney transplant six years ago due to
Lupus nephritis, for the last two years presented asymptomatic erythematous scaly
plaques on the abdomen and areas exposed to light. Post-transplantation
immunosuppressive medications included prednisone, mycophenolate sodium and
sirolimus. The histopathologic features were typical for epidermodysplasia
verruciformis. Epidermodysplasia verruciformis is a rare autosomal recessive
genodermatosis with increased susceptibility to specific strains of cutaneous human
papilloma virus. The term ''acquired epidermodysplasia verruciformis'' was recently
introduced to the literature and describes epidermodysplasia verruciformis occurring
in patients with impaired cell-mediated immunity. We report an additional case
associated to immunosuppression after kidney transplantation.</p>
      </abstract>
      <kwd-group>
        <kwd>Epidermodysplasia verruciformis</kwd>
        <kwd>Immunosuppression</kwd>
        <kwd>Kidney transplantation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Epidermodysplasia verruciformis (EV), initially described by Lewandowski and Lutz in
1922, is a rare genodermatosis, autosomal recessive or linked to the X chromosome,
characterized by susceptibility to chronic infection and disseminated by specific
strains of human papilloma virus (HPV), secondary to defect in cellular immunity. Its
onset is usually in early childhood, with the appearance of hypo or hyperpigmented
macules, pityriasis versicolor-like lesions, flat warts and early development of skin
carcinomas.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup> There are at least 20 types of HPVs associated with EV,
which include types 3, 5, 8, 9, 10, 12, 14, 15, 17, 19-25, 38, 29, 36, 46, 47, 49 and
50.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> These viruses have
oncogenic potential in these patients and around 30 to 60% of affected patients may
develop squamous cell carcinoma, usually in areas exposed to sunlight and in the fourth
decade of life.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> The term acquired EV
was recently introduced in the literature to describe EV developing in the
immunocompromised host, like carriers of acquired immunodeficiency virus, Hodgkin
disease and systemic lupus erythematosus.<sup><xref rid="r03" ref-type="bibr">3</xref>-<xref rid="r06" ref-type="bibr">6</xref></sup> Reports of acquired EV in
kidney transplanted patients are rare, with few cases described in the worldwide
literature to date.<sup><xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r09" ref-type="bibr">9</xref></sup>
</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 24-year-old male patient, student, presented for two years asymptomatic lesions in
areas exposed to light, which increased progressively in number. He used oral and
topical antifungals without improvement. He had history of systemic lupus erythematosus
for 11 years and kidney transplant due to renal failure secondary to lupus nephritis for
the last 6 years and, for this reason, he is undergoing immunosuppressant treatment with
sirolimus 1mg 2x/day, mycophenolate sodium 360mg/day and prednisone 10mg/day. There was
no history of consanguinity and affected relatives. On examination, he had numerous
erythematous papules and macules (pityriasis versicolor-like) on his face, neck,
V-shaped neckline, forearms and abdomen (<xref ref-type="fig" rid="f01">Figure
1</xref>). Histologic examination of the skin biopsy from abdomen revealed vacuolated
cells in the upper epidermis with a bubbly, bluish cytoplasm, thickened granular layer
and mild perivascular infiltrate in the superficial dermis, consistent with EV (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Erythematous papules, pityriasis versicolor-like plaques, on areas exposed to
light</p>
        </caption>
        <graphic xlink:href="abd-89-01-0144-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>A biopsy from the abdomen shows bubbly bluish cytoplasm and thickened granular
layer consistent with epidermodysplasia verruciformis</p>
        </caption>
        <graphic xlink:href="abd-89-01-0144-g02"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The pathogenesis of congenital EV remains unknown. On familial cases were found
mutations of EVER1/TMC6 and EVER2/TMC8 genes, present in chromosome 17q25. These
mutations could negatively regulate cell-mediated immunity, by diminishing the
capability of presenting peptides derived from HPV to T lymphocytes. Immunosuppressed
patients acquire susceptibility to HPV that cause EV, innocuous to the general
population, highlighting the role of cell-mediated immunity in resistance to the HPVs
that cause the syndrome. Similar to inherited EV, HPVs 5 and 8 are the most common
subtypes found in acquired EV.<sup><xref rid="r03" ref-type="bibr">3</xref></sup>
Although these are associated with the development of squamous cell carcinoma in
inherited EV, the potential for malignancy in acquired forms is uncertain.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> Our patient was on immunosuppressing
treatment with sirolimus, prednisone and mycophenolate sodium. Sirolimus acts on cell
immunity by T lymphocytes activation and proliferation inhibition. On cells, sirolimus
links itself to immunophilin, binding protein FK 12 (FKBP-12), in order to form an
immunosuppressant complex. The sirolimus/FKBP12 complex does not have effects over
calcineurin activity. This complex links itself to mTOR, an important regulatory kinase,
inhibiting its activity. This inhibition suppresses cytokine-induced T cell
proliferation, inhibiting the progression of phase G<sub>1 </sub>to phase S of the cell
cycle.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> Mycophenolate sodium is
a competitive and reversible inhibitor of inosine monophosphate dehydrogenase and,
therefore, inhibits the <italic>de novo</italic> synthesis of guanosine nucleotides,
with no DNA incorporation. Mycophenolate sodium has potent cytostatic effects over
lymphocytes, since B and T lymphocytes are critically dependent on purines for their
proliferation, whereas other types of cells can use alternative pathways. Prednisone
acts on growth, differentiation and maturation of the lymphocyte, inhibiting
proliferation of germinal centers of lymph nodes and spleen. The clinical and
histopathological manifestations of EV are similar in the two clinical forms. The
histopathological exam of lesions shows hyperkeratosis, acanthosis, keratinocytes with
ample cytoplasm and picnotic nuclei, located in the granular layer. The main objective
of EV treatment is to avoid the malignant transformation of lesions, for up to this
moment there is no effective therapy for the congenital and acquired forms. The use of
sunscreen is recommended for all patients at the time of diagnosis. Among the
therapeutic options are topical and systemic retinoids with antiproliferative action,
imiquimod, cryotherapy, 5-fluorouracil and topical cidofovir, none of them with proven
effectiveness.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Interferon can
be utilized due to its antiviral action mechanism, besides stimulating T cells. With
prolonged life expectancy of immunosuppressed patients it is fundamental that patients
undergo complete dermatological exams periodically, to detect skin alterations resulting
from cell immunity defects, among which EV stands out due to probable risk of carcinoma
development.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at the Dermatology Service of the University Center of the State of
Par&#xE1; (Centro Universit&#xE1;rio do Estado do Par&#xE1; - CESUPA) - Bel&#xE9;m (PA), Brazil.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Guerini</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Barbato</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Giunta</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Epidermodysplasia verruciformis: clinical presentation with varied
forms of lesions</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>S57</fpage>
          <lpage>S60</lpage>
          <pub-id pub-id-type="pmid">22068772</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>WRP</given-names>
            </name>
            <name>
              <surname>Neto</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Tyring</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Clinical aspects of epidermodysplasia verruciformis</article-title>
          <source>An Bras Dermatol</source>
          <year>2002</year>
          <volume>77</volume>
          <fpage>545</fpage>
          <lpage>546</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rogers</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Macgregor</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Nord</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Tyring</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rady</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Engler</surname>
              <given-names>DE</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Acquired epidermodysplasia verruciformis</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2009</year>
          <volume>60</volume>
          <fpage>315</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">19150275</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berger</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Sawchuk</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Leonardi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Langenberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tappero</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leboit</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <article-title>Epidermodysplasia verruciformis associated papillomavirus infection
complicating human immunodeficiency virus disease</article-title>
          <source>Br J Dermatol</source>
          <year>1991</year>
          <volume>124</volume>
          <fpage>79</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">1847068</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ellinger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Roussaki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fuchs</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Epidermodysplasia verruciformis in a patient with Hodgkin's disease:
characterization of a new papillomavirus type and interferon
treatment</article-title>
          <source>J Invest Dermatol</source>
          <year>1988</year>
          <volume>91</volume>
          <fpage>43</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">2838553</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garc&#xED;a-R&#xED;o</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Garcia-F-Villalta</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Daud&#xE9;n</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fraga</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-D&#xED;ez</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Epidermodysplasia Verruciformis-like Lesions in a Patient with
Systemic Lupus Erythematosus</article-title>
          <source>Acta Derm Venereol</source>
          <year>2003</year>
          <volume>83</volume>
          <fpage>229</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="pmid">12816165</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lutzner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Croissant</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ducasse</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Kreis</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Crosnier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Orth</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>A potentially oncogenic human papillomavirus (HPV5) found in two renal
allograft recipients</article-title>
          <source>J Invest Dermatol</source>
          <year>1980</year>
          <volume>75</volume>
          <fpage>353</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">6253573</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lutzner</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Orth</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dutronquay</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ducasse</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Kreis</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Crosnier</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Detection of human papillomavirus type 5 DNA in skin cancers of an
immunosuppressed renal allograft recipient</article-title>
          <source>Lancet</source>
          <year>1983</year>
          <volume>2</volume>
          <fpage>422</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="pmid">6135911</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xF3;mez-Bernal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez-Pazos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pereiro-Ferreir&#xF3;s</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Toribio</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Acquired epidermodysplasia verruciformis in a renal transplant
recipient</article-title>
          <source>Actas Dermosifiliogr</source>
          <year>2011</year>
          <volume>102</volume>
          <fpage>159</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="pmid">21292228</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campistol</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Griny&#xF3;</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Exploring treatment options in renal transplantation: The problems of
chronic allograft dysfunction and drug-related nephrotoxicity</article-title>
          <source>Transplantation</source>
          <year>2001</year>
          <volume>71</volume>
          <fpage>SS42</fpage>
          <lpage>SS51</lpage>
          <pub-id pub-id-type="pmid">11583488</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
